Orexo AB (publ) (STO:ORX)
Sweden
· Delayed Price · Currency is SEK 25.40
-0.55 (-2.12%)
At close: Mar 6, 2026
Orexo AB Employees
Orexo AB had 72 employees as of December 31, 2025. The number of employees decreased by 38 or -34.55% compared to the previous year.
Employees
72
Change (1Y)
-38
Growth (1Y)
-34.55%
Revenue / Employee
361.11K SEK
Profits / Employee
8.88M SEK
Market Cap
892.23M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cinclus Pharma Holding AB | 21 |
| Nanexa AB | 15 |
| Dicot Pharma AB | 4 |
| EQL Pharma AB | 55 |
| Moberg Pharma AB | 5 |
| Enzymatica AB | 20 |
| Cereno Scientific AB | 10 |
| Klaria Pharma Holding AB (publ.) | 4 |
Orexo AB News
- 1 day ago - Invitation & Agenda: Orexo R&D Day on March 24 - PRNewsWire
- 1 day ago - Orexo changes the organizational structure and management team to increase focus on development of new products - PRNewsWire
- 4 weeks ago - Orexo AB (publ) (ORXOY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Orexo AB (publ) (ORXOY) Discusses Divestment of US Rights to Zubsolv and Transition Agreement with Dexcel Pharma Transcript - Seeking Alpha
- 4 months ago - Orexo AB (publ) (ORXOY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Orexo's AmorphOX technology may pave the way for intranasal GLP-1 medication - PRNewsWire
- 9 months ago - Orexo to present clinical data for OX640 at the EAACI Congress - PRNewsWire
- 11 months ago - Orexo announces positive data for powder-based intranasal vaccine formulated with the AmorphOX technology - PRNewsWire